Physician

Gad Heilweil, M.D.

According to 2025 Medicare claims, Gad Heilweil, M.D. (NPI: 1386989440) practices ophthalmology in the Anaheim-Santa Ana-Irvine, CA market, with the plurality of this provider's patient population coming from Orange, CA. This provider's primary affiliated billing organization is JULES STEIN EYE INSTITUTE MEDICAL GROUP (NPI: 1326006966; TIN: 954379486) and primary practice location at 92708-6728.

Heilweil's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,169 traditional Medicare patients, billed 20,451 HCPCS/CPT codes, and received $2,253,207 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 375 prescription claims across 127 beneficiaries totaling $63,961 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 10 records totaling $270. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $858,581 to $2,253,207. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $15,694 to $63,961. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.3M2015 Medicare payment: $858,581 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,147,989 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,079,442 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,073,700 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,152,719 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,183,897 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,412,944 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,574,105 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,059,411 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,253,207 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154403,406$858,581
20165334,804$1,147,989
20175094,732$1,079,442
20186015,332$1,073,700
20197215,777$1,152,719
20207705,717$1,183,897
20219656,638$1,412,944
20221,1197,808$1,574,105
20231,26511,875$2,059,411
20241,16920,451$2,253,207

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$32K$65K2015 Drug cost: $15,694 (USD; Tot_Drug_Cst)2016 Drug cost: $34,080 (USD; Tot_Drug_Cst)2017 Drug cost: $32,755 (USD; Tot_Drug_Cst)2018 Drug cost: $26,258 (USD; Tot_Drug_Cst)2019 Drug cost: $41,407 (USD; Tot_Drug_Cst)2020 Drug cost: $47,248 (USD; Tot_Drug_Cst)2021 Drug cost: $50,368 (USD; Tot_Drug_Cst)2022 Drug cost: $58,295 (USD; Tot_Drug_Cst)2023 Drug cost: $64,720 (USD; Tot_Drug_Cst)2024 Drug cost: $63,961 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201577190$15,694
2016107314$34,080
201799277$32,755
2018114306$26,258
2019101303$41,407
2020110351$47,248
2021116364$50,368
2022128448$58,295
2023108311$64,720
2024127375$63,961

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system639711$99
67028Injection of drug into eye2361,535$97
92012Established patient problem focused exam of visual system5771,084$73
92134Imaging of retina9162,304$32
92250Photography of the retina233259$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept11308$20,753
RestasisCyclosporine14765$14,375
CyclosporineCyclosporine11810$8,639
Prednisolone AcetatePrednisolone Acetate1204,376$3,652
Ketorolac TromethamineKetorolac Tromethamine502,365$652

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$270Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Gad Heilweil, M.D.?

Tedicare shows public-source Medicare data for Gad Heilweil, M.D. (NPI 1386989440), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Gad Heilweil, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Gad Heilweil, M.D.?

Gad Heilweil, M.D. is linked to JULES STEIN EYE INSTITUTE MEDICAL GROUP (billing NPI 1326006966) in the available physician profile data.

Does Gad Heilweil, M.D. have Open Payments data?

Gad Heilweil, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.